The OP did not claim that the study sought to answer the questions posed. The article does answer the question 'Is it safe?' with the word 'Yes' so I believe you are actually in agreement with the OP and the OP did understand that it is really early to say that, hence the critique.
Sure reads to me like the OP is attacking the idea of developing a vaccine, not the media coverage.
I have always thought those medical trials are conducted under an NDA against the patient, meaning you do not only not know what group you are in, you are not even allowed to tell you are being observed in such a study (to prevent accidental unblinding).
The one thing we agreed to do was not to get an antibody test as that would unblind ourselves.
They never asked that or made us sign anything to that effect.
In this Phase 3 trial, they are measuring prevention of disease across ~10,000 people. They just want to see who tests positive for COVID and how sick they get. In this Phase, they aren't asking most groups about side effects or any subjective questions about symptom severity or anything like that where reading that someone was in a study would influence our opinion.
The on-going Phase 2/3 trials in the UK, South Africa and Brazil are designed to establish the efficacy of the vaccine under viral challenge. The idea is that you vaccinate a bunch of people (and an equally-sized control group) and wait around until a subset of them test positive for the virus. Then you unblind the groups and make sure that the people who got sick were in the control group. You also check for ADE (antibody dependent enhancement) to make sure the vaccine doesn't amplify the strength of the virus.
All your questions are valid, but this study doesn't claim to answer them. Those results are still forthcoming. Additionally, the risk of ADE is well understood and carefully considered in the design of these trials.
(Disclaimer - I'm a participant in the UK Phase 2/3 trial)